KCM
CRBU icon

Kynam Capital Management’s Caribou Biosciences CRBU Stock Holding History

Kynam Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Hold
2,503,302
– – 0.24% 28
2026
Q1 		$4.76M Hold
2,503,302
– – 0.29% 35
2025
Q4 		$3.98M Sell
2,503,302
-564,472
-18% -$1.18M 0.25% 32
2025
Q3 		$7.15M Hold
3,067,774
– – 0.53% 29
2025
Q2 		$3.87M Sell
3,067,774
-201,373
-6% -$198K 0.42% 24
2025
Q1 		$2.99M Buy
3,269,147
+863,000
+36% +$1.12M 0.25% 29
2024
Q4 		$3.83M Buy
2,406,147
+50,000
+2% +$101K 0.23% 28
2024
Q3 		$4.62M Buy
2,356,147
+709,445
+43% +$1.45M 0.35% 23
2024
Q2 		$2.7M Buy
1,646,702
+578,175
+54% +$1.85M 0.21% 25
2024
Q1 		$5.49M Hold
1,068,527
– – 0.57% 21
2023
Q4 		$6.12M Hold
1,068,527
– – 0.68% 22
2023
Q3 		$5.11M Buy
+1,068,527
New +$6.63M 0.84% 21

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Kynam Capital Management's CRBU Position: Q2 2026 in Review

Kynam Capital Management held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 2,503,302 shares worth $4.41M. The position accounts for 0.24% of the portfolio, ranked #28.

Kynam Capital Management first reported a position in CRBU in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.15M in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Kynam Capital Management held 2,503,302 shares of Caribou Biosciences worth $4.41M as of Q2 2026.
  • Kynam Capital Management left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up 0.24% of Kynam Capital Management's portfolio in Q2 2026, its #28 holding.
  • Kynam Capital Management first reported a position in Caribou Biosciences in Q3 2023 and has held it in 12 quarters since.
  • Kynam Capital Management's Caribou Biosciences position peaked at $7.15M in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Kynam Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.